Perturbation of epidermal growth factor clearance after radioiodination and its implications

Journal of Pharmaceutical Sciences

Volumn 86, Issue 3, 1997, Pages 290-296

  Kuo, Be Sheng ^a   Nordblom, Gerald D ^a   Wright, D Scott ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRICHLOROACETIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG CLEARANCE; DRUG HALF LIFE; IMMUNOPRECIPITATION; OXIDATIVE STRESS; PROTEIN BINDING; RADIOIODINATION; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0031042626     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960370e     Document Type: Article

References (52)

1. Cohen, S.; Taylor, J. M. Epidermal growth factor: chemical and biological characterization. Recent Prog. Harm. Res. 1974, 30, 533-550.
2. Gregory, H.; Wilshire, I. R. The isolation of the urogastrone inhibitors of gastric acid secretion from human urine. Hoppe-Seyler's Z. Physiol. Chem. 1975, 356, 1765-1774.
3. Gregory, H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975, 257, 325-327.
4. Cohen, S.; Carpenter, G. Human epidermal growth factor: isolation and chemical and biological properties. Proc. Natl. Acad. Sci. U.SA. 1975, 72, 1317-1321.
5. Carpenter, G.; Cohen, S. Epidermal growth factor. Ann. Rev. Biochem. 1979, 48, 193-296.
6. Buckley, A.; Davison, J. M.; Kamerath, C. D.; Wolt, T. B.; Woodward, S. C. Sustained release of epidermal growth factor accelerates wound repair. Proc. Natl. Acad. Sci. U.SA. 1985, 82, 7340-7344.
7. Calabro, A.; Milani, S.; Palandini, I.; Orsini, B.; Salvador, G.; Surrenti, C. Role of epidermal growth factor in peptic ulcer healing. Dig. Dis. Sci. 1995, 40, 2497-2504.
8. Wollenberg, G. K.; Harris, L.; Farber, E.; Hayes, M. A. Inverse relationship between epidermal growth factor induced proliferation and expression of high affinity surface epidermal grwoth factor receptors in rat hepatocytes. Lab. Invest. 1989, 60, 254-259.
9. Green, M. R.; Basketter, D. A.; Couchman, J. R.; Rees, D. A. Distribution and number of epidermal growth factor, receptor in skin is related to epithelial cell growth. Dev. Biol. 1983, 100, 56-63.
10. Yanai, S.; Sugiyama, Y.; Kim, D. C.; Sato, H.; Fuwa, T.; Iga, T.; Hanano, M. Binding of human epidermal growth factor to tissue homogenates of the rat. Chem. Pharm. Bull. 1987, 35, 4891-4897.
11. Hilarie, R. J. S.; Hradek, G. T.; Jones, A. L. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high capacity uptake system. Proc. Natl. Acad. Scci. U.S.A. 1983, 80, 3791-3801.
12. Kim, D. C.; Sigiyama, Y.; Sato, H.; Fuwa, T.; Iga, T.; Hanano, M. Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J. Pharm. Sci. 1988, 77, 200-207.
13. Yanai, S.; Sugiyama, Y.; Iga, T.; Fuwa, T.; Hanano, M. Kinetic analysis of the down regulation of epidermal growth factor receptors in rats in vivo. Am. J. Physiol. 1990, 258, C593-C598.
14. 125I-epidermal growth factor in intracellular organelles. J. Biol. Chem. 1984, 259, 3047-3052.
15. 125I-epidermal growth factor. J. Biol. Chem. 1984, 259, 3053-3057.
16. Kim, D. C.; Sugiyama, Y.; Fuwa, T.; Sakamoto, S.; Iga, T.; Hanano, M. Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats. Biochem. Pharmacol. 1989, 38, 241-249.
17. Kuo, B.-S.; Kusmik, W. F.; Poole, J. C.; Elsea, C. J.; Chang, J.; Hwang, K. K. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats. Drug Metab. Dispos. 1992, 38, 241-249.
18. Tyson, L. M.; Browne, G.; Kenkin, G.; Thorburn, G. D. The fate and uptake of murine epidermal growth factor in the sheep. J. Endocrinol. 1989, 123, 121-130.
19. 131I-labelled epidermal growth factor in the pig visulized by dynamic scintigraphy. J. Endocrinol. 1994, 144, 5-12.
20. Kuo, B.-S.; Nordblom, G. D.; Ducdeck, R. C.; Kirkish, L. S.; Wright, D. S. Disposition kinetics of human epidermal growth factor (hEGF1-53) and its truncated fragment (hEGF1-48) in rats. Drug. Metab. Dispos. 1996, 24, 96-104.
21. Murakami, T.; Kawakita, H.; Kishimoto, M.; Higasi, Y.; Amagase, H.; Hayashi, T.; Nojima, N.; Fuwa, T.; Yata, N. Intravenous and subcutaneous pharmacokinetics and rectal bioavailability of human growth factor in the presence of absorption promoter in rats. Int. J. Pharm. 1988, 46, 9-17.
22. Hollenberg, M. D.; Gregory, H. Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives. Mol. Pharmacol. 1980, 17, 314-320.
23. Kienhuis, C. B. M.; Heuvel, J. J. T. M.; Ross, H. A.; Swinkels, L. M. J. W.; Foekens, J. A.; Benraad, Th. J. Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand. Clin. Chem. 1991, 37, 1749-1755.
24. Hollenmans, H. J. G.; Bertina, R. M. Scatchard plot and heterogeneity in binding affinity of labeled and unlabeled ligand. Clin. Chem. 1975, 21, 1769-1773.
25. Kermode, J. C. Means for the assessment of radioligand purity and its importance in receptor-binding studies. Biochem. J. 1988, 252, 521-528.
26. Sherman, A. S.; Harwig, S.; Hayne, O. A. Macromolecular complexes formed as the result of Chloramine-T radioiodination of proteins. Int. J. Appl. Radiat. Isot. 1974, 25, 81-85.
27. Lee, D. S. C.; Griffiths, B. W. Comparative studies of lodo-bead and Chloramine-T methods for the radioiodination of human alpha-fetoprotein. J. Immunol. Meth. 1984, 74, 181-189.
28. 125I-labeled mouse epidermal growth factor radioactivity by six different methods. Clin. Chem. 1992, 38, 681-686.
29. Marti, U.; Burwen, S. J.; Baker, M. E.; Ruling, S.; Feren, A. M.; Jones, A. L. Effect of oxidative iodination of epidermal growth factor on its binding and secretion by hepatocytes. J. Cell Biochem. 1989, 40, 109-119.
30. Torell, J. I.; Johansson, B. G. Protein iodination with solid state lactoperoxidase. Biochemistry 1974, 13, 1014-1021.
31. Gregory, H.; Thomas, C. E.; Young, J. A.; Willshire, I. R.; Garner, A. The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action. Regul. Pept. 1988, 22, 217-226.
32. Sizemore, N.; Dudeck, R. C.; Barksdale, C. M.; Nordblom, G. D.; Mueller, W. T.; McConnell, P.; Wright, D. S.; Guglietta, A.; Kuo, B.-S. Development and validation of two solid-phase enzyme immunoassays (ELISA) for quantitation of human epidermal growth factors (hEGFs). Pharm. Res. 1996, 13, 1088-1094.
33. 125I-EGF to cell surface receptors. A useful artifact of Chloramine-T treatment. J. Biol. Chem. 1982, 257, 42-45.
34. Linsley, P. S.; Blifeld, C.; Wrann, M.; Fox, C. F. Direct linkage of epidermal growth factor to its receptor. Nature 1979, 278, 745-748.
35. Linsley, P. S.; Fox, C. F. Direct linkage of EGF to its receptor: characterization and biological relevance. J. Supramolec. Struct. 1980, 14, 441-459.
36. Mellman, I.; Fuchs, R.; Helenius, A. Acidification of the endocytotic pathways. Ann. Rev. Biochem. 1986, 55, 663-700.
37. Schechter, Y.; Hernacz, L.; Cuatrecasas, P. Epidermal growth factor: biological activity requires persistent occupation of high-affinity cell surface receptors. Proc. Natl. Acad. Sci. U.SA. 1978, 75, 5788-5791.
38. Dunn, W. A.; Connolly, T. P.; Hubbard, A. L. Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: Receptor pathway. J. Cell Biol. 1986, 102, 24-36.
39. Gladhaug, I. P.; Christoffersen, T. Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. J. Biol. Chem. 1988, 263, 12199-12203.
40. Jorgensen, P. E.; Poulsen, S. S.; Nexo, E. Distribution of I.V. administered epidermal growth factor in the rat. Regul. Pept. 1988, 23, 161-169.
41. Leonard, J. L.; Visser, T. J. Biochemistry of deiodination. In: Thyroid Hormone Metabolism; Hennemann, G., Ed.; Marcel Dekker: New York, 1986; pp 189-229.
42. Ryan, M. P.; Peavy, D. E.; Frank, B. H.; Duckworth, W. C. The degradation of monoiodotyrosyl insulin isomers by insulin protease. Endocrinology 1984, 115, 591-599.
43. Jorgensen, M. D.; Monrad, J. D.; Brondum, L.; Diensen, B. Pharmacokinetics of biosynthetic and pituitary human growth hormones in rats. Pharmacol. Toxicol. 1988, 63, 129-134.
44. Zioncheck, T. F.; Chen, S. A.; Richardson, L.; Mora-Worms, M.; Lucas, C.; Lewis, D.; Green, J. D.; Mordenti, J. Pharmacokinetics and tissue distribution of recombinant human transforming growth factor Betai after topical and intravenous administration in male rats. Pharm. Res. 1984, 11, 213-220.
45. 125I-insulin: kinetics of interaction with its receptors and rate of degradation in vivo. Am. J. Physiol. 1980, 239, E3-E11.
46. Harris, R.; Frade, L. G.; Creighton, L. J.; Gascione, P. S.; Alexandron, M. M.; Poole, S.; Gaffney, P. J. Investigation by HPLC of the catabolism of recombinant tissue plasminogen activator in the rat. Thromb. Haemost. 1988, 60, 107-112.
47. Pang, X. P.; Hershman, J. M.; Perkary, A. E. Plasma disappearance and organ distribution of recombinant human tumor necrosis factor-alpha in rats. Lymphok. Cytok. Res. 1991, 10, 301-306.
48. Lai, W. H.; Cameron, P. H.; Wada, I.; Doherty, J.-J.; Kay, D. G.; Poser, B. I.; Bergeron, J. J. M. Ligand-mediated internalization recycling, and down regulation of the epidermal growth factor in vivo. J. Cell Biol. 1989, 109, 2741-2749.
49. O'Keefe, E.; Hollenberg, M. D.; Cuatrecasas, P. EGF characteristics of specific binding in membranes from liver, placenta and other tissues. Arch. Biochem. Biophys. 1974, 164, 518-526.
50. Sugiyama, Y.; Hanano, M. Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body. Pharm. Res. 1989, 6, 192-202.
51. Bauer, R. J.; Leigh, S. D.; Birr, C. A.; Bernhard, S. L.; Fang, M.; Der, K.; Ihejeto, N. D.; Carrol, S. F. Alteration of the Pharmacokinetics of small proteins by iodination. Biopharmceut. Drug Dispos. 1996, 17, 761-774.
52. Reddy, C. C.; Niyogi, S. K.; Wells, A.; Wiley, H. S.; Lauffenburger, D. A. Engineering epidermal growth factor for enhanced mitogenic potency. Nature Biotechnol. 1996, 14, 1696-1699.